Actively Recruiting

Phase 3
Age: 12Years - 18Years
All Genders
NCT07255209

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight

Led by Innovent Biologics (Suzhou) Co. Ltd. · Updated on 2026-01-08

180

Participants Needed

1

Research Sites

148 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is designed to assess the efficacy and safety of multiple doses of IBI362 in Chinese adolescent subjects with obesity or overweight. It plans to enroll 180 adolescents (aged ≥12 and \<18 years) who have failed to achieve a 5 kg weight reduction after at least 12 weeks of dietary and exercise intervention.

CONDITIONS

Official Title

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight

Who Can Participate

Age: 12Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female participants aged 512 years and C18 years at the time of signing the informed consent/assent form.
  • BMI at screening meeting obesity criteria as defined by WS/T 586-2018 or overweight with at least one weight-related comorbidity: prediabetes, type 2 diabetes, hypertension, dyslipidemia, fatty liver disease, or obstructive sleep apnea syndrome.
  • Weight change less than 5 kg after at least 12 weeks of diet and exercise alone before screening (per self/parental report).
Not Eligible

You will not qualify if you...

  • Prior diagnosis of type 1 diabetes.
  • Pre-pubertal participants (Tanner Stage I).
  • History of or planned bariatric surgery (except liposuction/abdominoplasty or acupuncture for weight loss done more than 1 year before screening).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Children's Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310052

Actively Recruiting

Loading map...

Research Team

X

Xiaoyan li

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight | DecenTrialz